Mannans and health, with a special focus on glucomannans

Food Research International

Volumn 50, Issue 1, 2013, Pages 384-391

  Tester, Richard F ^a   Al Ghazzewi, Farage H ^a  

^a GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

Author keywords

Health benefits; Konjac glucomannans; Mannans; Physiological disorders; Prebiotic

Indexed keywords

HEALTH BENEFITS; KONJAC GLUCOMANNANS; MANNANS; PHYSIOLOGICAL DISORDERS; PREBIOTICS;

ESCHERICHIA COLI; HEALTH; PHYSIOLOGY;

DISEASES;

ESCHERICHIA COLI;

EID: 84870534387     PISSN: 09639969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.foodres.2012.10.037     Document Type: Review

References (98)

1. Albrecht S., Van Muiswinkel G.C.J., Schols H.A., Voragen A.G., Gruppen H. Introducing capillary electrophoresis with laser-induced fluorescence detection (CE-LIF) for the characterisation of konjac glucomannan oligosaccharides and their in vitro fermentation behaviour. Journal Agriculture Food Chemistry 2009, 57:3867-3876.
2. Al-Ghazzewi F.H., Khanna S., Tester R.F., Piggott J. The potential use of hydrolysed konjac glucomannan as a prebiotic. Journal of the Science of Food and Agriculture 2007, 87:1758-1766.
3. Alonso-Sande M., Teijeiro-Osorio D., Remuñán-López C., Alonso M.J. Glucomannan, a promising polysaccharide for biopharmaceutical purposes. European Journal of Pharmaceutics and Biopharmaceutics 2009, 72:453-462.
4. Arvill A., Bodin L. Effect of short-term ingestion of konjac glucomannan on serum cholesterol in healthy men. The American Journal of Clinical Nutrition 1995, 61:585-589.
5. Azezli A.D., Bayraktaroglu T., Orhan Y. The use of konjac glucomannan to lower serum thyroid hormones in hyperthyroidism. Journal of the American College of Nutrition 2007, 26:663-668.
6. Banlunara W., Bintvihok A., Kumagai S. Immunohistochemical study of proliferating cell nuclear antigen (PCNA) in duckling liver fed with aflatoxin B1 and esterified glucomannan. Toxicon 2005, 46:954-957.
7. Barnich N., Denizot J., Darfeuilli-Michaud A. E. coli-mediated gut inflammation in genetically predisposed Crohn's disease patients. Pathologie-Biologie 2010, 10.1016/j.patbio.2010.01.004.
8. Becker P.M., Galletti S. Food and feed components for gut health-promoting adhesion of E. coli and Salmonella enterica. Journal of the Science of Food and Agriculture 2008, 88:2026-2035.
9. Benites V., Gilharry R., Gernat A.G., Murillo J.G. Effect of dietary mannan oligosaccharide from Bio-Mos or SAF-mannan on live performance of broiler chickens. Journal of Applied Poultry Research 2008, 17:471-475.
10. Bozkurt M., Küçükyýlmaz K., Çatlý A.U., Çnar M. The effect of single or combined dietary supplementation of prebiotics, organic acid and probiotics on performance and slaughter characteristics of broilers. South African Journal of Animal Science 2009, 39:197-205.
11. Brennan C.S., Blake D.E., Ellis P.R., Schofield J.D. Effects of guar galactomannan on wheat bread microstructure and on the in vitro and in vivo digestibility of starch in bread. Journal of Cereal Science 1996, 24:151-160.
12. Chen H.-L., Cheng H.-C., Liu Y.-J., Liu S.-Y., Wu W.-T. Konjac acts as a natural laxative by increasing stool bulk and improving colonic ecology in healthy adults. Nutrition 2006, 22:1112-1119.
13. Chen H.-L., Cheng H.-C., Wu W.-T., Liu Y.-J., Liu S.-Y. Supplementation of konjac glucomannan into a low fibre Chinese diet promoted bowel movement and improved colonic ecology in constipated adults: A placebo-controlled, diet controlled trial. Journal of the American College of Nutrition 2008, 27:102-108.
14. Chen H.-L., Fan Y.-H., Chen M.-E., Chan Y. Unhydrolysed and hydrolysed konjac glucomannans modulated caecal and faecal microflora in Balb/c mice. Nutrition 2005, 21:1059-1064.
15. Chen H.-L., Sheu W.-H., Tai T.-S., Liaw Y.P., Chen Y.C. Konjac supplement alleviated hypercholesterolemia and hyperglycemia in type 2 diabetic subjects - A randomised double-blind trial. Journal of the American College of Nutrition 2003, 22:36-42.
16. Chua M., Baldwin T.C., Hocking T.J., Chan K. Traditional uses and potential health benefits of Amorphophallus konjac K. Koch ex N.E. Br. Journal of Ethnopharmacology 2010, 128:268-278.
17. Connolly M.L., Lovegrove J.A., Tuohy K.M. Konjac glucomannan hydrolysate beneficially modulates bacterial composition and activity within the faecal microbiota. Journal of Functional Foods 2010, 2:219-224.
18. Corrigan A., Horgan K., Clipson N., Murphy R.A. Effect of dietary supplementation with a Saccharomyces cerevisiae mannan oligosaccharide on the bacterial community structure of broiler cecal contents. Applied and Environmental Microbiology 2011, 77:6653-6662.
19. Darfeuille-Michaud A., Boudeau J., Bulois P., Neut C., Glasser A.L., Barnich N., et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 2004, 127:412-421.
20. Davis S.E., Lewis B.A. Physiological effects of mannans, galactomannans, and glucomannans. Physiological effects of food carbohydrates 1975, vol. 15:296-311. American Chemical Society, New York, (ISBN13: 9780841202467). A. Jeanes, J. Hodge (Eds.).
21. EC (European Commission) Commission Directive 2001/30/EC of 2001, amending directive 96/77/EC laying down specific purity criteria on food additives other than colours and sweeteners Accessed 30 Nov 2009. Available at:. http://eurlex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2001:146:0001:0023:EN:PDF.
22. Eden C.S., Hagberg L., Hanson L.A., Korhonen T., Leffler H., Olling S. Adhesion of Escherichia coli in urinary tract infection. CIBA Foundation Symposium 1981, 80:161-187.
23. Elamir A.A., Tester R.F., Al-Ghazzewi F.H., Kaal H.Y., Ghalbon A.A., Elmegrahai N.A., et al. Effects of konjac glucomannan hydrolysates on the gut microflora of mice. Nutrition and Food Science 2008, 38:422-429.
24. FCC (Food Chemicals Codex) Revised monograph-konjac flour Accessed 30 Nov. 2009. Available at:. http://www.nap.edu/html/fcc/konjac.pdf.
25. Franceschi S., Maso L.D., Augustin L., Negri E., Parpinel M., Boyle P., et al. Dietary glycemic load and colorectal cancer risk. Annals of Oncology 2001, 12:173-178.
26. Frieri G., Pimpo M.T., Scarpignato C. Management of colonic diverticular disease - Focus on rifaximin. Digestion 2006, 73:58-66.
27. Gallaher D.D., Gallaher C.M., Mahrt G.J., Carr T.P., Hollingshead C.H., Hesslink R., et al. A glucomannan and chitosan fibre supplement decreases plasma cholesterol and increases cholesterol excretion in overweight normocholesterolemic humans. Journal of the American College of Nutrition 2002, 2:428-433.
28. Gibson G.R., Roberfroid M.B. Dietary modulation of the colonic microbiota: Introducing the concept of prebiotics. The Journal of Nutrition 1995, 125:1401-1412.
29. Grieshop C.M., Flickinger E.A., Bruce K.J., Patil A.R., Czamecki-Maulden G.L., Fahey G.C. Gastrointestinal and immunological responses of senior dogs to chicory and mannan-oligosaccharides. Archives of Animal Nutrition 2004, 58:483-493.
30. Hamman J.H. Composition and applications of Aloe vera leaf gel. Molecules 2008, 13:1599-1616.
31. Heaton K.W., Thornton J.R., Emmett P.M. Treatment of Crohn's disease with an unrefined- carbohydrate, fibre-rich diet. British Medical Journal 1979, 2:764-766.
32. Hopkins M.J., Macfarlane G.T. Nondigestible oligosaccharides enhance bacterial colonization resistance against Clostridium difficile in vitro. Applied and Environmental Microbiology 2003, 69:1920-1927.
33. Huang D., Liu Q., Yang F., Huang F. The health-promoting function and the application of konjac mannooligosaccharides (KMOS). Food Science and Technology (China) 2007, October, 159-161.
34. Huang C.Y., Zhang M.Y., Peng S.S., Hong J.R., Wang X., Jiang H.J., et al. Effect of konjac food on blood glucose level in patients with diabetes. Biomedical and Enviromental Sciences 1990, 3:123-131.
35. 13C NMR spectroscopy. Carbohydrate Polymers 2003, 53:183-189.
36. Keithley J., Swanson B. Glucomannan and obesity: A critical review. Alternative Therapies in Health and Medicine 2005, 11:30-34.
37. Khanna, S. (2003). The chemical, physical and nutritional properties of the plant polysaccharide konjac glucomannan. PhD Thesis, Glasgow Caledonian University.
38. Khanna S., Tester R.F. Influence of purified konjac glucomannan on the gelatinisation and retrogradation properties of maize and potato starches. Food Hydrocolloids 2006, 20:567-576.
39. Kiliaan, A. J., Groot, J. A., Timmermans, J. W., Meulen, J. V. D., Van Laere, K. M. J., & Bijlsma, P. B., (2001). Nutritional compositions which contain non-digestible polysaccharides and use thereof to reduce transport through tight junctions. Patent WO200133975.
40. King S.S., Young D.A., Nequin L.G., Carnevale E.M. Use of specific sugars to inhibit bacterial adherence to equine endometrium in vitro. American Journal of Veterinary Research 2000, 61:446-449.
41. Kitamoto N., Kato Y., Ohnaka T., Yokota M., Tanaka T., Tsuji K. Bactericidal effects of konjac fluid on several food poisoning bacteria. Journal of Food Protection 2003, 66:1822-1831.
42. Klemm P., Schembri M.A. Fimbrial surface display systems in bacteria: From vaccines to random libraries. Microbiology (Reading, England) 2000, 146:3025-3032.
43. Korhonen T.K., Vaisanen V., Kallio P., Nurmiaho-Lassila E.L., Ranta H., Siitonen A., et al. The role of pili in the adhesion of Escherichia coli to human urinary tract epithelial cells. Scandinavian Journal of Infectious Diseases 1982, (Suppl. 33):26-31.
44. Latella G., Pimpo M.T., Sottili S., Zippi M., Viscido A., Chiaramonte M., et al. Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon. International Journal of Colorectal Disease 2003, 18:55-62.
45. Liepman A.H., Nairn C.J., Willats W.G.T., Sorensen I., Roberts A.W., Keegstra K. Functional genomic analysis supports conservation of function among cellulose synthase-like A gene family members and suggests diverse roles of mannans in plants. Plant Physiology 2007, 143:1881-1893.
46. Livieri C., Novazi F., Lorini R. The use of highly purified glucomannan based fibres in childhood obesity. La Pediatria Medica e Chirurgica 1992, 14:195-198.
47. Loening-Baucke V., Miele E., Staiano A. Fibre (glucomannan) is beneficial in the treatment of childhood constipation. Pediatrics 2004, 113:E259-E264.
48. Madrigal-Santillan E., Alvarez-Conzalez I., Marquez-Marquez R., Velázquez-Guadarrama N., Madrigal-Bujaidar E. Inhibitory effect of mannan on the toxicity produced in mice fed aflatoxin B-1 contaminated corn. Archives of Environmental Contamination and Toxicology 2007, 53:466-472.
49. Mangan D.F., Snyder I.S. Mannose-sensitive interaction of Escherichia coli with human peripheral leukocytes in vitro. Infection and Immunity 1979, 26:520-527.
50. Mann J., Truswell A.S. Essentials of human nutrition 2007, 443. Oxford University Press, New York.
51. Martin H.M., Campbell B.J., Hart C.A., Mpofu C., Nayar M., Singh R., et al. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology 2004, 127:80-93.
52. Marzio L., Del Bianco R., Donne M.D., Pieramico O., Cuccurullo F. Mouth-to-cecum transit time in patients affected by chronic constipation: effect of glucomannan. The American Journal of Gastroenterology 1989, 84:888-891.
53. Matsuura Y. Degradation of konjac glucomannan by enzymes in human faeces and formation of short-chain fatty acids by intestinal anaerobic bacteria. Journal of Nutritional Science and Vitaminology 1998, 44:423-436.
54. Meier H., Reid J.S.G. Reserve polysaccharides other than starch in higher plants. Encyclopaedia of plant physiology 1982, vol. 13A:418-471. Springer, Berlin.
55. Melga P., Giusto M., Ciuchi E., Giusti R., Prando R. Dietary fibre in the dietetic therapy of diabetes mellitus. Experimental data with purified glucomannans. European Review for Medical and Pharmacological Sciences 1992, 14:367-373.
56. Miguel J.C., Rodriguez-Zas S.L., Pettigrew J.E. Efficacy of a mannan oligosaccharide (Bio-Mos) for improving nursery pig performance. Journal of Swine Health and Production 2004, 12:296-307.
57. Millane R.P., Hendrixson T.L. Crystal structures of mannan and glucomannans. Carbohydrate Polymers 1994, 25:245-251.
58. Mizutani T., Mitsuoka T. Effect of konjac mannan on 1,2 dimethylhydrazine induced intestinal carcinogenisis in fischer 344 rats. Cancer Letters 1983, 19:l-6.
59. Moreira L.R.S., Filho E.X.F. An overview of mannan structure and mannan-degrading enzyme systems. Applied Microbiology and Biotechnology 2008, 79:165-178.
60. Nakajima N., Ishihara K., Matsuura Y. Dietary-fiber degrading enzymes from a human intestinal Clostridium and their application to oligosaccharide production from non-starchy polysaccharides using immobilized cells. Applied Microbiology and Biotechnology 2002, 59:182-189.
61. Ofek I., Mosek A., Sharon N. Mannose-specific adherence of Escherichia coli freshly extracted in the urine of patients with urinary tract infections, and of isolates subcultured from the infected urine. Infection and Immunity 1981, 34:708-711.
62. Onishi N., Kawamoto S., Nishimura M., Nakano T., Aki T., Shigeta S., et al. A new immuno-modulatory function of low-viscous konjac glucomannan with a small particle size: Its oral intake suppresses spontaneously occurring dermatitis in NC/Nga mice. International Archives of Allergy and Immunology 2005, 136:258-265.
63. Onishi N., Kawamoto S., Suzuki H., Santo H., Aki T., Shigeta S., et al. Dietary pulverised konjac glucomannan suppresses scratching behaviour and skin inflammatory immune responses in NC/Nga mice. International Archives of Allergy and Immunology 2007, 144:95-104.
64. Onishi N., Kawamoto S., Ueda K., Yamanaka Y., Katayama A., Suzuki H., et al. Dietary pulverised konjac glucomannan prevents the development of allergic rhinitis-like symptoms and IGE response in mice. Bioscience, Biotechnology, and Biochemistry 2007, 71:2551-2556.
65. Onishi, N., Kunihiko, H., & Hisao, S. (2003). Drug and food containing glucomannan for inhibiting IgE antibody. Patent EP20031283045.
66. Oomizu S., Onishi N., Suzuki H., Ueda K., Mochizuki M., Morimoto K., et al. Oral administration of pulverised konjac glucomannan prevents the increase of plasma immunoglobulin E and immunoglobulin G levels induced by the injection of syngeneic keratinocyte extracts in BALB/c mice. Clinical and Experimental Allergy 2006, 36:102-110.
67. Pan X.-D., Chen F.-G., Wu T.-X., Tang H.-G., Zhao Z.-Y. Prebiotic oligosaccharides change the concentrations of short-chain fatty acids and the microbial population of mouse bowel. Journal of Zhejiang University. Science 2009, B10:258-263.
68. Papi C., Ciaco A., Koch M., Capurso L. Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double-blind placebo-controlled trial. Alimentary Pharmacology & Therapeutics 1995, 9:33-39.
69. Papi C., Koch M., Capurso L. Management of diverticular disease: Is there room for rifaximin. Chemotherapy 2005, 51:110-114.
70. Passaretti S., Franzoni M., Comin U., Donzelli R., Rocca F., Colombo E., et al. Action of glucomannans on complaints in patients affected with chronic constipation: A multicentric clinical evaluation. The Italian Journal of Gastroenterology 1991, 23:421-425.
71. Petruzziello L., Iacopini F., Bulajic M., Shah S., Costamagna G. Review article: Uncomplicated diverticular disease of the colon. Alimentary Pharmacology & Therapeutics 2006, 23:1379-1391.
72. Preston R.D. Plants without cellulose. Scientific American 1968, 216:102-108.
73. Ratcliffe I., Williams P.A., Viebke C., Meadows J. Physicochemical characterization of konjac glucomannan. Biomacromolecules 2005, 6:1977-1986.
74. Rhodes J.M. The role of Escherichia coli in inflammatory bowel disease. Gut 2007, 56:610-612.
75. Roberfroid M.B. Prebiotics: The concept revisited. The Journal of Nutrition 2007, 137:830S-837S.
76. Schaeffer A.J., Amundsen S.K., Jones J.M. Effect of carbohydrates on adherence of Escherichia coli to human urinary tract epithelial cells. Infection and Immunity 1980, 30:531-537.
77. Schley P.D., Field C.J. The immune-enhancing effects of dietary fibres and prebiotics. The British Journal of Nutrition 2002, 87(Suppl. 2):S221-S230.
78. Schröder R., Atkinson R.G., Redgwell R.J. Re-interpreting the role of endo-β-mannanases as mannan endotransglycosylase/hydrolases in the plant cell wall. Annals of Botany 2009, 104:197-204.
79. Signorelli P., Croce P., Dede A.A. Clinical study of the use of a combination of glucomannan with lactulose in the constipation of pregnancy. Minerva Ginecologica 1996, 48:577-582.
80. Silvia S. Nutritional options for infant constipation. Nutrition 2007, 23:615-616.
81. Skjoedt M.O., Palarasah Y., Rasmussen K., Vitved L., Salomonsen J., Kliem A., et al. Two mannose-binding lectin homologues and an MBL-associated serine protease are expressed in the gut epithelia of the urochordate species Ciona intestinalis. Developmental and Comparative Immunology 2010, 34:59-68.
82. Smith D.L., Nagy T.R., Wilson L.S., Dong S., Barnes S., Allison D.B. The effect of mannan oligosaccharide supplementation on body weight gain and fat accrual in C57Bl/6J mice. Obesity (Silver Spring) 2010, 18:995-999.
83. Srivastava M., Kapoor V.P. Seed galactomannans: An overview. Chemistry & Biodiversity 2005, 2:295-317.
84. Staiano A., Simeone D., Del Giudice E., Miele E., Tozzi A., Toraldo C. Effect of the dietary fibre glucomannan on chronic constipation in neurologically impaired children. The Journal of Pediatrics 2000, 136:41-45.
85. Suzuki H., Oomizu S., Yanase Y., Onishi N., Uchida K., Mihara S., et al. Hydrolysed konjac glucomannan suppresses IgE production in mice B cells. International Archives of Allergy and Immunology 2010, 152:122-130.
86. Tester R.F., Al-Ghazzewi F.H. Utilisation of glucomannans for health. Food hydrocolloids: Characteristics, properties and structures 2009, 1-9. Nova Science Publishers, Inc., New York. C.S. Hollingworth (Ed.).
87. Tizard I.R., Carpenter R.H., McAnalley B.H., Kemp M.C. The biological activities of mannans and related complex carbohydrates. Molecular Biotherapy 1989, 1:290-296.
88. Topping D.L., Clifton P.M. Short-chain fatty acids and human colonic function: roles of resistant starch and non-starch polysaccharides. Physiological Reviews 2001, 81:1031-1064.
89. Van Zyl W.H., Rose S.H., Trollope K., Görgens J.F. Fungal β-mannanases: Mannan hydrolysis, heterologous production and biotechnological applications. Process Biochemistry 2010, 45:1203-1213.
90. Venter C.S., Vorster H.H., Van Der Nest D.G. Comparison between physiological effects of konjac-glucomannan and propionate in baboons fed "Western" diets. The Journal of Nutrition 1990, 120:1046-1053.
91. Vuksan V., Sievenpiper J.L., Owen R., Swilley J.A., Spadafora P., Jenkins D.J., et al. Beneficial effects of viscous dietary fibre from konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial. Diabetes Care 2000, 23:9-14.
92. Vuksan V., Sievenpiper J.L., Xu Z., Wong E.Y., Jenkins A.L., Beljan-Zdravkovic U., et al. Konjac-mannan and American ginseng: Emerging alternative therapies for type 2 diabetes mellitus. Journal of the American College of Nutrition 2001, 20:370-380.
93. Walsh D.E., Yaghoubian V., Behforooz A. Effect of glucomannan on obese patients: A clinical study. International Journal of Obesity 1984, 8:289-293.
94. Wang C.-H., Lai P., Chen M.-E., Chen H.-L. Antioxidative capacity produced by Bifidobacterium- and Lactobacillus acidophilus-mediated fermentations of konjac glucomannan and glucomannan oligosaccharides. Journal of the Science of Food and Agriculture 2008, 88:1294-1300.
95. Wu W.-T., Chen H.-L. Effects of konjac glucomannan on putative risk factors for colon carcinogenesis in rats fed a high-fat diet. Journal of Agriculture and Food Chemistry 2011, 59:989-994.
96. Wu W.-T., Cheng H.-C., Chen H.-L. Ameliorative effects of konjac glucomannan on human faecal β-glucuronidase activity, secondary bile acid levels and faecal water toxicity towards Caco-2 cells. The British Journal of Nutrition 2011, 105:593-600.
97. Yang Y., Gao S., Wang H., Chen S., Ma L. Studies on the effect of konjac oligosaccharides on blood sugar and serum cholesterol in the diabetic mice. Journal of Hebei University(Natural Science Edition) 2001, 3. doi: cnki:ISSN:1000-2375.0.2001-03-024.
98. Ye S.-L., Lin M.-S., Chen H.-L. Partial hydrolysis enhances the inhibitory effects of konjac glucomannan from Amorphophallus konjac C. Koch on DNA damage induced by faecal water in Caco-2 cells. Food Chemistry 2010, 119:614-618.